Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Inventory (2023 - 2025)

Bioregenx has reported Inventory over the past 3 years, most recently at $106931.0 for Q4 2025.

  • For Q4 2025, Inventory fell 3.75% year-over-year to $106931.0; the TTM value through Dec 2025 reached $106931.0, down 3.75%, while the annual FY2025 figure was $106931.0, 3.75% down from the prior year.
  • Inventory for Q4 2025 was $106931.0 at Bioregenx, down from $109378.0 in the prior quarter.
  • Over five years, Inventory peaked at $217529.0 in Q4 2023 and troughed at $106931.0 in Q4 2025.
  • A 3-year average of $148399.0 and a median of $140438.0 in 2025 define the central range for Inventory.
  • Biggest five-year swings in Inventory: tumbled 48.93% in 2024 and later decreased 3.75% in 2025.
  • Year by year, Inventory stood at $217529.0 in 2023, then tumbled by 48.93% to $111094.0 in 2024, then fell by 3.75% to $106931.0 in 2025.
  • Business Quant data shows Inventory for BRGX at $106931.0 in Q4 2025, $109378.0 in Q3 2025, and $134228.0 in Q2 2025.